StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) shareholders

BNRNasdaqServices-Medical Laboratories
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
2M of 1M shares
Institutional holders
17
3 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
8 buys · 0 sales
Net bought $11.65M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Neil Nanpeng Shen (“ns”)
Joint filing with Hsg Holding Limited (“hsg Holding”) (8.00%), Snp China Enterprises Limited (“snp China Enterprises”) (8.00%)
6,846,5678.00%13G (passive) amendmentDec 31, 2023
Yi Shi4,384,2055.10%13G (passive)Dec 31, 2023
Yue Tang
Joint filing with Kynam Capital Management, LP (11.01%), Kynam Capital Management GP, LLC (11.01%)
994,88311.01%13G (passive) amendmentSep 30, 2025
Ding Chun R
Joint filing with Crcm LP (5.38%), Crcm LLC (5.38%) and 1 more
486,4265.38%13G (passive)Dec 16, 2025
Kynam Capital Management, LP
Joint filing with Kynam Capital Management GP, LLC (13.97%), Yue Tang (13.97%)
013.97%13G (passive) amendmentMar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BNRValueChange% of portfolio
Kynam Capital Management, LP1,238,563189.99%$10.52M+11,0080.58%
Crcm LP423,99465.04%$3.55M+141,8971.17%
Renaissance Technologies LLC52,8388.11%$442.25K+17,4310.00%
Morgan Stanley43,5946.69%$364.88K+28,3220.00%
Nikko Asset Management Americas, Inc.29,7244.56%$257.71K−4130.00%
Sumitomo Mitsui Trust Holdings, Inc.29,7244.56%$248.79K−4130.00%
Bank Of America Corp /De/29,1644.47%$244.10K–0.00%
Citadel Advisors LLC27,2884.19%$236.59K+9,6190.00%
HSG Holding Ltd21,2123.25%$177.54K–0.01%
UBS Group AG17,9162.75%$149.96K+17,5080.00%
Almanack Investment Partners, LLC.16,1982.48%$135.58KNew0.02%
XTX Topco Ltd13,6212.09%$118.09KNew0.00%
Bnp Paribas Arbitrage, Snc2,8000.43%$23.44K–0.00%
Tower Research Capital LLC (TRC)1,2420.19%$10.40K+1,2140.00%
JPMorgan Chase & Co1660.03%$1.34K−210.00%
Royal Bank of Canada730.01%$1.00KNew0.00%
BlackRock, Inc.40.00%$33–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026172M100.0%3 / 73 / 20M0M
Q1 2026162M100.0%3 / 37 / 30M0M
Q4 2025162M100.0%3 / 44 / 30M0M
Q3 2025161M100.0%2 / 43 / 30M0M
Q2 2025171M100.0%1 / 35 / 20M1M
Q1 2025182M100.0%0 / 18 / 30M0M
Q4 2024212M100.0%4 / 47 / 10M0M
Q3 2024182M100.0%2 / 37 / 10M0M
Q2 2024182M100.0%3 / 48 / 50M0M
Q1 2024202M100.0%4 / 27 / 30M0M
Q4 2023192M100.0%2 / 37 / 110M0M
Q3 2023282M100.0%2 / 312 / 60M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

5 funds held BNR in Q3 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of BNRValue% of fundAs of
Fidelity Nasdaq Composite Index Fund3,9620.61%$36.93K0.00%May 31, 2026
Invesco Golden Dragon China ETF3,8580.59%$33.95K0.03%Jul 31, 2026
Emerging Markets Core Equity 2 Portfolio1,3600.21%$11.97K0.00%Jul 31, 2026
Emerging Markets Social Core Equity Portfolio1,2270.19%$10.80K0.00%Jul 31, 2026
The Emerging Markets Small Cap Series9170.14%$8.07K0.00%Jul 31, 2026
World ex U.S. Core Equity Portfolio6160.09%$5.42K0.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Xiaozhi HuSenior Director in Finance––Mar 17, 2026
Yusheng HanDirector18,404,0862823.11%Jul 2, 2026
Feng DengDirector1,188,025182.24%Mar 18, 2026
Wendy W. HayesDirector––Mar 17, 2026
Zhihong ZhangDirector1,061,990162.90%Mar 17, 2026
Licen Lisa XuDirector22,7183.48%Mar 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Yusheng Han
Director
Jun 26, 2026Buy+24,900$8.00$199.20K18,404,086
Yusheng Han
Director
Jun 24, 2026Buy+250,000$8.00$2.00M18,379,186
Yusheng Han
Director
Jun 23, 2026Buy+5,990$7.50$44.93K18,129,186
Yusheng Han
Director
Jun 22, 2026Buy+104,650$7.45$779.64K18,123,196
Yusheng Han
Director
Jun 16, 2026Buy+111,110$9.00$999.99K18,018,546
Yusheng Han
Director
Jun 12, 2026Buy+210,000$9.25$1.94M17,907,436
Yusheng Han
Director
Jun 11, 2026Buy+24,760$8.74$216.40K17,697,436
Yusheng Han
Director
Mar 31, 2026Buy+314,870$17.36$5.47M17,672,676

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.3
At 0M shares a day
Change since last report
-6.9%
From 0M shares
Short volume, 20 days
27.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Burning Rock Biotech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,736 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?